Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Todd J Suscovich & Galit Alter. (2015) In situ production of therapeutic monoclonal antibodies. Expert Review of Vaccines 14:2, pages 205-219.
Read now
Read now
Anne B Tolstrup, Torben P Frandsen & Søren Bregenholt. (2006) Development of recombinant human polyclonal antibodies for the treatment of complex human diseases. Expert Opinion on Biological Therapy 6:9, pages 905-912.
Read now
Read now
Arturo Casadevall & Liise-anne Pirofski. (2005) The potential of antibody-mediated immunity in the defence against biological weapons. Expert Opinion on Biological Therapy 5:10, pages 1359-1372.
Read now
Read now
Articles from other publishers (20)
Thomas J. Gardner, Kathryn R. Stein, J. Andrew Duty, Toni M. Schwarz, Vanessa M. Noriega, Thomas Kraus, Thomas M. Moran & Domenico Tortorella. (2016) Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope protein. Nature Communications 7:1.
Crossref
Crossref
Mats Ohlin & Cecilia Söderberg-Nauclér. (2015) Human antibody technology and the development of antibodies against cytomegalovirus. Molecular Immunology 67:2, pages 153-170.
Crossref
Crossref
K. Kubelkova & A. Macela. (2015) Putting the Jigsaw Together - A Brief Insight Into the Tularemia. Open Life Sciences 10:1.
Crossref
Crossref
Les P NagataJonathan P Wong, Wei-gang Hu & Josh Q Wu. (2013) Vaccines and therapeutics for the encephalitic alphaviruses. Future Virology 8:7, pages 661-674.
Crossref
Crossref
Andrew Hiatt, Larry Zeitlin & Kevin J. Whaley. (2013) Multiantibody Strategies for HIV. Clinical and Developmental Immunology 2013, pages 1-11.
Crossref
Crossref
Manuela Calin. 2012. Antibody-Mediated Drug Delivery Systems. Antibody-Mediated Drug Delivery Systems
229
266
.
Torben P. Frandsen, Henrik Naested, Søren K. Rasmussen, Peter Hauptig, Finn C. Wiberg, Lone Kjaer Rasmussen, Anne Marie Valentin Jensen, Pia Persson, Margareta Wikén, Anders Engström, Yun Jiang, Susan J. Thorpe, Cecilia Förberg & Anne B. Tolstrup. (2011) Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use. Biotechnology and Bioengineering 108:9, pages 2171-2181.
Crossref
Crossref
Pia Persson, Anders Engström, Lone K. Rasmussen, Erland Holmberg & Torben P. Frandsen. (2010) Development of Mass Spectrometry Based Techniques for the Identification and Determination of Compositional Variability in Recombinant Polyclonal Antibody Products. Analytical Chemistry 82:17, pages 7274-7282.
Crossref
Crossref
T. Nagarajan, Charles E. Rupprecht, Scott K. Dessain, P. N. Rangarajan, D. Thiagarajan & V. A. Srinivasan. 2008. Human Antibody Therapeutics for Viral Disease. Human Antibody Therapeutics for Viral Disease
67
101
.
Robert V. House. (2007) Systems integration: An effective and innovative response to emerging biological threats. Vaccine 25:16, pages 3170-3174.
Crossref
Crossref
Claire Newcombe & Anthony R. Newcombe. (2007) Antibody production: Polyclonal-derived biotherapeutics. Journal of Chromatography B 848:1, pages 2-7.
Crossref
Crossref
Stefan Dübel. (2007) Recombinant therapeutic antibodies. Applied Microbiology and Biotechnology 74:4, pages 723-729.
Crossref
Crossref
John de KruifAlexander B.H. BakkerWilfred E. MarissenR. Arjen KramerMark ThrosbyCharles E. Rupprecht & Jaap Goudsmit. (2007) A Human Monoclonal Antibody Cocktail as a Novel Component of Rabies Postexposure Prophylaxis. Annual Review of Medicine 58:1, pages 359-368.
Crossref
Crossref
Andrey P. Anisimov & Kingsley K. Amoako. (2006) Treatment of plague: promising alternatives to antibiotics. Journal of Medical Microbiology 55:11, pages 1461-1475.
Crossref
Crossref
Josephine L. Klitgaard, Vincent W. Coljee, Peter S. Andersen, Lone K. Rasmussen, Lars S. Nielsen, John S. Haurum & Søren Bregenholt. (2006) Reduced Susceptibility of Recombinant Polyclonal Antibodies to Inhibitory Anti-Variable Domain Antibody Responses. The Journal of Immunology 177:6, pages 3782-3790.
Crossref
Crossref
John S. Haurum. (2006) Recombinant polyclonal antibodies: the next generation of antibody therapeutics?. Drug Discovery Today 11:13-14, pages 655-660.
Crossref
Crossref
Kurt C. Almquist, Michael D. McLean, Yongqing Niu, Greg Byrne, Fernando C. Olea-Popelka, Coral Murrant, Jack Barclay & J. Christopher Hall. (2006) Expression of an anti-botulinum toxin A neutralizing single-chain Fv recombinant antibody in transgenic tobacco. Vaccine 24:12, pages 2079-2086.
Crossref
Crossref
Andrea Buchacher & Günter Iberer. (2006) Purification of intravenous immunoglobulin G from human plasma – aspects of yield and virus safety. Biotechnology Journal 1:2, pages 148-163.
Crossref
Crossref
Brian Paddle. 2005. Inhalation Toxicology, Second Edition. Inhalation Toxicology, Second Edition
983
1015
.
A. Cecília A. Roque, M. Ângela Taipa & Christopher R. Lowe. (2005) An artificial protein L for the purification of immunoglobulins and Fab fragments by affinity chromatography. Journal of Chromatography A 1064:2, pages 157-167.
Crossref
Crossref